Dynamic and ligand-selective interactions of vitamin D receptor with retinoid X receptor and cofactors in living cells

Molecular Pharmacology

Volumn 80, Issue 6, 2011, Pages 1147-1155

  Choi, Mihwa ^a   Yamada, Sachiko ^a   Makishima, Makoto ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

25 ADAMANTYL 1ALPHA,25 DIHYDROXY 2 METHYLENE 22,23 DIDEHYDRO 19,26,27 TRINOR 20 EPIVITAMIN D3; CALCITRIOL; COLECALCIFEROL DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 24A1; HETERODIMER; HOMODIMER; LIGAND; LITHOCHOLIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DIMERIZATION; DISSOCIATION; DRUG EFFECT; EMBRYO CELL; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HETERODIMERIZATION; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; MEDIATOR; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; COENZYMES; COS CELLS; HCT116 CELLS; HEK293 CELLS; HUMANS; LIGANDS; LITHOCHOLIC ACID; MOLECULAR DYNAMICS SIMULATION; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS;

EID: 81555195473     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.074138     Document Type: Article

References (40)

1. Adachi R, Shulman AI, Yamamoto K, Shimomura I, Yamada S, Mangelsdorf DJ, and Makishima M (2004) Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol Endocrinol 18:43-52. (Pubitemid 38073152)
2. Bai Y and Giguére V (2003) Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells. Mol Endocrinol 17:589-599. (Pubitemid 36406378)
3. Baneyx G, Baugh L, and Vogel V (2001) Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer. Proc Natl Acad Sci USA 98:14464-14468. (Pubitemid 33121414)
4. Carlberg C (2003) Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 88:274-281.
5. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol Cell Biol 14:3329-3338.
6. Choi M and Makishima M (2009) Therapeutic applications for novel nonhypercalcemic vitamin D receptor ligands. Expert Opin Ther Pat 19:593-606.
7. Erickson MG, Moon DL, and Yue DT (2003) DsRed as a potential FRET partner with CFP and GFP. Biophys J 85:599-611. (Pubitemid 36753662)
8. Feige JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, and Desvergne B (2005) Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J Biol Chem 280:17880-17890. (Pubitemid 41389029)
9. Fujiki R, Kim MS, Sasaki Y, Yoshimura K, Kitagawa H, and Kato S (2005) Ligand-induced transrepression by VDR through association of WSTF with acetylated histones. EMBO J 24:3881-3894. (Pubitemid 41637995)
10. Han S, Li T, Ellis E, Strom S, and Chiang JY (2010) A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol 24:1151-1164.
11. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, and Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349. (Pubitemid 28146215)
12. Hu X, Li Y, and Lazar MA (2001) Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Mol Cell Biol 21:1747-1758. (Pubitemid 32156395)
13. Igarashi M, Yoshimoto N, Yamamoto K, Shimizu M, Ishizawa M, Makishima M, DeLuca HF, and Yamada S (2007) Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro- 19,27-dinor-20-epi-vitamin D3 (ADMI3). Arch Biochem Biophys 460:240-253. (Pubitemid 46589392)
14. 3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Mol Pharmacol 71:1298-1311.
15. Karmakar S, Gao T, Pace MC, Oesterreich S, and Smith CL (2010) Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor. Mol Endocrinol 24:1187-1202.
16. Kim JY, Son YL, and Lee YC (2009) Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. Mol Endocrinol 23:251-264.
17. 3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 20:305-317.
18. 3receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol 16:1006-1016.
19. Li Y, Suino K, Daugherty J, and Xu HE (2005) Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol Cell 19:367-380. (Pubitemid 41074892)
20. Llopis J, Westin S, Ricote M, Wang Z, Cho CY, Kurokawa R, Mullen TM, Rose DW, Rosenfeld MG, Tsien RY, et al. (2000) Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator- activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription. Proc Natl Acad Sci USA 97:4363-4368. (Pubitemid 30226138)
21. Ma Y, Khalifa B, Yee YK, Lu J, Memezawa A, Savkur RS, Yamamoto Y, Chintalacharuvu SR, Yamaoka K, Stayrook KR, et al. (2006) Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest 116:892-904.
22. Makishima M (2005) Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J Pharmacol Sci 97:177-183.
23. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, and Mangelsdorf DJ (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316. (Pubitemid 34522785)
24. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, and Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284:1362-1365. (Pubitemid 29289663)
25. Makishima M and Yamada S (2005) Targeting the vitamin D receptor: advances in drug discovery. Expert Opin Ther Pat 15:1133-1145. (Pubitemid 41358432)
26. Matilainen JM, Malinen M, Turunen MM, Carlberg C, and Väisänen S (2010) The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells. J Biol Chem 285:24174-24183.
27. 3 catabolism in macrophages. Toxicol Sci 109:50-58.
28. Nagpal S, Na S, and Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687. (Pubitemid 41127276)
29. Nakabayashi M, Yamada S, Yoshimoto N, Tanaka T, Igarashi M, Ikura T, Ito N, Makishima M, Tokiwa H, DeLuca HF, et al. (2008) Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. J Med Chem 51:5320-5329.
30. 3 administration in mice. Drug Metab Dispos 37:2037-2044.
31. 3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors. J Bone Miner Res 17:2196-2205.
32. Peräkylä M, Malinen M, Herzig KH, and Carlberg C (2005) Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol Endocrinol 19:2060-2073. (Pubitemid 41124201)
33. Prüfer K, Racz A, Lin GC, and Barsony J (2000) Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem 275:41114-41123. (Pubitemid 32054941)
34. Rosenfeld MG, Lunyak VV, and Glass CK (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428. (Pubitemid 43830648)
35. Sánchez-Martínez R, Zambrano A, Castillo AI, and Aranda A (2008) Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol Cell Biol 28:3817-3829. (Pubitemid 351732915)
36. Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AA, Miner JN, and Diamond MI (2005) The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions. Proc Natl Acad Sci USA 102:9802-9807. (Pubitemid 40993649)
37. Shang Y, Hu X, DiRenzo J, Lazar MA, and Brown M (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
38. Tagami T, Lutz WH, Kumar R, and Jameson JL (1998) The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253:358-363. (Pubitemid 29026708)
39. Väisänen S, Dunlop TW, Sinkkonen L, Frank C, and Carlberg C (2005) Spatiotemporal activation of chromatin on the human CYP24 gene promoter in the presence of 1α,25-dihydroxyvitamin D3. J Mol Biol 350:65-77. (Pubitemid 40804732)
40. Zwart W, Griekspoor A, Berno V, Lakeman K, Jalink K, Mancini M, Neefjes J, and Michalides R (2007) PKA-induced resistance to tamoxifen is associated with an altered orientation of ERα towards co-activator SRC-1. EMBO J 26:3534-3544. (Pubitemid 47236876)